Ken Paxton, Texas Attorney General, has launched a lawsuit targeting the producer of Tylenol, accusing the company of deliberately spreading misleading information that associates the widely used painkiller with autism spectrum disorder (ASD) in children. This legal move, highlighted by Houston Public Media, reflects heightened vigilance regarding consumer rights and corporate responsibility within the pharmaceutical sector. The case represents a pivotal effort by state officials to confront what they deem unfounded claims that could adversely affect public health.

The complaint outlines several key accusations against the manufacturer, including:

• Promotion of inaccurate health assertions in advertising materials
• Omission of clear disclaimers about the absence of scientific consensus
• Distortion of autism research to imply a causal link with acetaminophen use